IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q1 2014 Holdings

Filed 2014-05-14 | 16 holdings | $18.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$18.5M1,744,35699.1%
GW PharmaceuticalsCOM36197T103$38.3K644,3760.2%
Anacor Pharmaceuticals IncCOM032420101$30.9K1,545,9990.2%
Dyax CorpCOM26746E103$18.0K2,000,8590.1%
Keryx Biopharmaceuticals IncCOM492515101$17.0K1,000,2730.1%
Heron Therapeutics Inc(HRTX)COM427746102$15.2K1,095,7340.1%
DBV TechnologiesCOMF2927N109$12.0K480,0000.1%
Ironwood Pharmaceuticals Inc(IRWD)COM46333X108$11.1K900,0000.1%
Ocera TherapeuticsCOM67552A108$7.4K703,7300.0%
Flamel Technologies S.A.COM338488109$6.7K500,0000.0%
TherapeuticsMD IncCOM88338N107$5.3K846,5000.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$4.9K303,5030.0%
Chelsea Therapeutics International LtdCOM163428105$4.4K788,3700.0%
Alexza Pharmaceuticals IncCOM015384100$1.1K247,8120.0%
Xencor Inc(XNCR)COM98401F105$1.0K88,4000.0%
Versartis IncCOM92529L102$57119,0000.0%